Evans, A E <br/><br/>
Effect of CEP-751 (KT-6587) on neuroblastoma xenografts expressing TrkB.  [electronic resource] 

 -  Medical and pediatric oncology  Jan 2001 
 - 181-4 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0098-1532 
<br/><br/><label>Standard No.: </label>10.1002/1096-911X(20010101)36:1<181::AID-MPO1043>3.0.CO;2-Q  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Agents--therapeutic use<br/>Apoptosis--drug effects<br/>Brain-Derived Neurotrophic Factor--pharmacology<br/>Carbazoles--therapeutic use<br/>Enzyme Activation--drug effects<br/>Enzyme Inhibitors--therapeutic use<br/>Female<br/>Humans<br/>In Situ Nick-End Labeling<br/>Mice<br/>Mice, Nude<br/>Neoplasm Proteins--antagonists & inhibitors<br/>Neuroblastoma--drug therapy<br/>Phosphorylation--drug effects<br/>Protein Processing, Post-Translational--drug effects<br/>Receptor, trkB--antagonists & inhibitors<br/>Reverse Transcriptase Polymerase Chain Reaction<br/>Transfection<br/>Tumor Cells, Cultured--metabolism<br/>Xenograft Model Antitumor Assays